The selective serotonin reuptake inhibitors (SSRIs) have the best established tolerance and safety profile of the available antidepressants. Evidence for this conclusion comes from controlled clinical trials, post-marketing surveillance, prescription audits and case reports. Comparative studies are
Safety and tolerability of combined specific serotonin reuptake inhibitors, and Reversible Monoaminoxidase Inhibitor A (Moclobemide)
โ Scribed by K. Chaleby; Yf. Semaan; S. Al Sughair
- Book ID
- 119175427
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- French
- Weight
- 132 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0924-9338
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
This retrospective study was undertaken with the objective of determining how effective and safe moclobemide, a specific and reversible inhibitor of monoamine oxidase-A (RIMA), is when used in combination with specific serotonin re-uptake inhibitors (SSRIs), in a clinical setting. A thorough chart r
Considerable progress has been made in improving the tolerability of antidepressant drugs. The classical tricyclic antidepressants (TCA) are still, however, the standard for ecacy. The selective serotonin reuptake inhibitors are better tolerated that the tricyclics, but their ecacy in major depressi